Omadacycline versus moxifloxacin for community-acquired bacterial pneumonia (OPTIC-2): a phase 3b, randomised, double-blind, multicentre, controlled, noninferiority trial.

Saved in:
Bibliographic Details
Title: Omadacycline versus moxifloxacin for community-acquired bacterial pneumonia (OPTIC-2): a phase 3b, randomised, double-blind, multicentre, controlled, noninferiority trial.
Authors: File TM Jr; Summa Health, Akron, OH, USA.; Northeast Ohio Medical University, Rootstown, OH, USA., Kaye KS; Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA., Ihor S; Communal Non-commercial Enterprise 'City Polyclinic No. 9' of the Kharkiv City Council, Kharkiv, Ukraine., Hovbakh I; Communal Non-commercial Enterprise 'City Polyclinic No. 9' of the Kharkiv City Council, Kharkiv, Ukraine., Katsarava V; Tbilisi State Medical University and Ingorokva State High Technology Medical Clinic, Tbilisi, Georgia., Kirsch C; Paratek Pharmaceuticals, Inc., King of Prussia, PA, USA., Soni K; MMS Holdings Canton, MI, USA., Gupta K; MMS Holdings Canton, MI, USA., Manley A; Paratek Pharmaceuticals, Inc., King of Prussia, PA, USA., Deck DH; Paratek Pharmaceuticals, Inc., King of Prussia, PA, USA., Anastasiou D; Paratek Pharmaceuticals, Inc., King of Prussia, PA, USA., Chitra S; Paratek Pharmaceuticals, Inc., King of Prussia, PA, USA., Villano S; Paratek Pharmaceuticals, Inc., King of Prussia, PA, USA.
Source: EClinicalMedicine [EClinicalMedicine] 2025 Nov 20; Vol. 90, pp. 103656. Date of Electronic Publication: 2025 Nov 20 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: The Lancet Country of Publication: England NLM ID: 101733727 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5370 (Electronic) Linking ISSN: 25895370 NLM ISO Abbreviation: EClinicalMedicine Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2589-5370
DOI:10.1016/j.eclinm.2025.103656